PPARA and neoplasm: Furthermore, a number of studies have discovered that abnormal PPARs and PPAR target gene expression are frequently related to the development and progression of cancer [7–9], and agonists of the PPAR pathway, such as thiazolidinediones, are typically regarded antiproliferative in tumor cells [10].